Implementation of ReSPECT in acute hospitals: A retrospective observational study.


Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
09 2022
Historique:
received: 26 04 2022
revised: 09 06 2022
accepted: 24 06 2022
pubmed: 3 7 2022
medline: 17 8 2022
entrez: 2 7 2022
Statut: ppublish

Résumé

To evaluate, in UK acute hospitals, the early implementation of the Recommended Summary Plan for Emergency Care and Treatment (ReSPECT), which embeds cardiopulmonary resuscitation (CPR) recommendations within wider emergency treatment plans. To understand for whom and how the process was being used and the quality of form completion. A retrospective observational study evaluating emergency care and treatment planning approaches used in acute UK hospitals (2015-2019), and in six English hospital trusts the extent of ReSPECT use, patient characteristics and completion quality in a sample 3000 patient case notes. The use of stand-alone Do Not Attempt Cardiopulmonary Resuscitation forms fell from 133/186 hospitals in 2015 to 64/186 in 2019 (a 38% absolute reduction). ReSPECT accounted for 52% (36/69) of changes. In the six sites, ReSPECT was used for approximately 20% of patients (range 6%-41%). They tended to be older, to have had an emergency medical admission, to have cognitive impairment and a lower predicted 10 year survival. Most (653/706 (92%)) included a 'not for attempted resuscitation' recommendation 551/706 (78%) had at least one other treatment recommendation. Capacity was not recorded on 13% (95/706) of forms; 11% (79/706) did not record patient/family involvement. ReSPECT use accounts for 52% of the change, observed between 2015 and 2019, from using standalone DNACPR forms to approaches embedding DNACPR decisions within in wider emergency care plans in NHS hospitals in the UK. Whilst recommendations include other emergencies most still tend to focus on recommendations relating to CPR. Completion of ReSPECT forms requires improvement. https://www.isrctn.com/ISRCTN11112933.

Identifiants

pubmed: 35779800
pii: S0300-9572(22)00585-8
doi: 10.1016/j.resuscitation.2022.06.020
pii:
doi:

Banques de données

ISRCTN
['ISRCTN11112933']

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

26-35

Subventions

Organisme : Department of Health
ID : 15/15/09
Pays : United Kingdom

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of Competing Interest CH, GDP and ZF are members of the ReSPECT natioal working group. CB is Clinical Lead for ReSPECT at the Resuscitation Council UK. CH, GDP, ZF, AMS, FG, MU, RL and DG revieced grants from the UK National Insititue for Health Research during the study. The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Claire A Hawkes (CA)

Division of Applied Technologies in Clinical Care, Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King's College London, SE1 8AW. Electronic address: Claire.hawkes@kcl.ac.uk.

James Griffin (J)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

Karin Eli (K)

Health Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

Frances Griffiths (F)

Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.

Anne-Marie Slowther (AM)

Health Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

Zoë Fritz (Z)

THIS (The Healthcare Improvement Studies) Institute, University of Cambridge, CB2 0QQ, UK.

Martin Underwood (M)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, CV4 7A, UK.

Catherine Baldock (C)

Resuscitation Council, UK.

Doug Gould (D)

Intensive Care National Audit & Research Centre, London WC1V 6AZ, UK.

Richard Lilford (R)

University of Birmingham, UK.

Claire Jacques (C)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

Jane Warwick (J)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

Gavin D Perkins (GD)

Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH